Privacy Policy
Signals Blog

Contributors

Categories

Engineering a future-proof stem cell policy

In a field as fast-paced as regenerative medicine, it’s vital that policy isn’t always playing catch-up. I caught up with Amy Zarzeczny’s presentation at the 2021 Till & McCulloch Meetings to find out how policy can stay ahead — or at least keep...

Taking appropriate steps towards gene editing in Canada

Patrick Bedford is the new Manager of Clinical Translation and Regulatory Affairs at CCRM.  He holds a Master’s Degree in Bioethics and Health Law, and has over 10 years of experience applying federal regulations to emerging biotechnologies in Canada.   Back in...

Stem cells: The quiescent issue in US elections

[pullquote]How will Romney’s opinion change in light of papers, which describe healthy mice being created from iPS cells?[/pullquote]As 2012 slowly creeps on we can finally see November’s Presidential Election in the United States on the horizon marking the end of a...